According to our results, it seems that treatment of MCT-induced PAH rat models with PA and QS has reduced the proliferation of PASMCs by reducing the expression of PARP1, subsequently increasing the expression of miR-204, and reducing NFATc2 and HIF1α in the lungs. This evidence concerns the gene NFATC2 and pulmonary arterial hypertension.